This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Deutsches Krebsforschungszentrum, Ruprecht-Karls-Universitat Heidelberg. Active years: 2014-2018.
Location History:
- Mainz, DE (2014)
- Eppstein, DE (2016 - 2018)
Company Filing History:
3 out of 159 
2 out of 63 
Years Active: 2014-2018
Title: The Innovative Contributions of Sandra Steinbrink
Introduction
Sandra Steinbrink is a notable inventor based in Eppstein, Germany. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target the Wnt signaling pathway. Her work is particularly relevant in the context of cancer treatment, showcasing her commitment to advancing medical science.
Latest Patents
Sandra Steinbrink holds 3 patents that focus on chromene derivatives and their analogs as Wnt pathway antagonists. These patents detail compounds of formula (IIc), where X and X can independently be N or CR, with R potentially being the same or different. The compounds also include Y, Y, Y, and Y, which can independently be N or CR, with specific conditions regarding the number of N groups. These compounds, along with their solvates, hydrates, and pharmaceutically acceptable salts, are designed for modulating Wnt signaling pathway activity and are intended for use as medicaments, particularly in cancer treatment.
Career Highlights
Throughout her career, Sandra has worked with prestigious institutions such as the Deutsches Krebsforschungszentrum and Ruprecht-Karls-Universität Heidelberg. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in cancer therapies.
Collaborations
Sandra has collaborated with esteemed colleagues, including Michael Boutros and Corinna Koch. These partnerships have further enriched her research and innovation efforts.
Conclusion
Sandra Steinbrink's work exemplifies the intersection of innovation and medical research, particularly in the fight against cancer. Her patents and collaborations highlight her significant role in advancing therapeutic options for patients.